List of Tables
Table 1. Global Intravitreal Injection of Anti-VEGF Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Intravitreal Injection of Anti-VEGF Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Intravitreal Injection of Anti-VEGF Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Intravitreal Injection of Anti-VEGF Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Intravitreal Injection of Anti-VEGF Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Intravitreal Injection of Anti-VEGF Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Intravitreal Injection of Anti-VEGF Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Intravitreal Injection of Anti-VEGF Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Intravitreal Injection of Anti-VEGF Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Intravitreal Injection of Anti-VEGF Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Intravitreal Injection of Anti-VEGF Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravitreal Injection of Anti-VEGF Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Intravitreal Injection of Anti-VEGF Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravitreal Injection of Anti-VEGF Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Intravitreal Injection of Anti-VEGF Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Intravitreal Injection of Anti-VEGF Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Intravitreal Injection of Anti-VEGF Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Intravitreal Injection of Anti-VEGF Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Intravitreal Injection of Anti-VEGF Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Intravitreal Injection of Anti-VEGF Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Intravitreal Injection of Anti-VEGF Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Intravitreal Injection of Anti-VEGF Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Intravitreal Injection of Anti-VEGF Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Intravitreal Injection of Anti-VEGF Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Intravitreal Injection of Anti-VEGF Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Intravitreal Injection of Anti-VEGF Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Intravitreal Injection of Anti-VEGF Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Intravitreal Injection of Anti-VEGF Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Intravitreal Injection of Anti-VEGF Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Intravitreal Injection of Anti-VEGF Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Intravitreal Injection of Anti-VEGF Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Intravitreal Injection of Anti-VEGF Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Intravitreal Injection of Anti-VEGF Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Intravitreal Injection of Anti-VEGF Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Intravitreal Injection of Anti-VEGF Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Intravitreal Injection of Anti-VEGF Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Intravitreal Injection of Anti-VEGF Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Intravitreal Injection of Anti-VEGF Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Intravitreal Injection of Anti-VEGF Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Intravitreal Injection of Anti-VEGF Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Intravitreal Injection of Anti-VEGF Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Intravitreal Injection of Anti-VEGF Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Intravitreal Injection of Anti-VEGF Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Intravitreal Injection of Anti-VEGF Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Intravitreal Injection of Anti-VEGF Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Intravitreal Injection of Anti-VEGF Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Intravitreal Injection of Anti-VEGF Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Intravitreal Injection of Anti-VEGF Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Intravitreal Injection of Anti-VEGF Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Intravitreal Injection of Anti-VEGF Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Intravitreal Injection of Anti-VEGF Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Intravitreal Injection of Anti-VEGF Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Intravitreal Injection of Anti-VEGF Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Intravitreal Injection of Anti-VEGF Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Intravitreal Injection of Anti-VEGF Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Intravitreal Injection of Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis Intravitreal Injection of Anti-VEGF Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche Intravitreal Injection of Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Roche Intravitreal Injection of Anti-VEGF Drugs Product
Table 79. Roche Recent Developments/Updates
Table 80. Regeneron Company Information
Table 81. Regeneron Description and Business Overview
Table 82. Regeneron Intravitreal Injection of Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Regeneron Intravitreal Injection of Anti-VEGF Drugs Product
Table 84. Regeneron Recent Developments/Updates
Table 85. Bayer Company Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Intravitreal Injection of Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Bayer Intravitreal Injection of Anti-VEGF Drugs Product
Table 89. Bayer Recent Developments/Updates
Table 90. Samsung Bioepis Company Information
Table 91. Samsung Bioepis Description and Business Overview
Table 92. Samsung Bioepis Intravitreal Injection of Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Samsung Bioepis Intravitreal Injection of Anti-VEGF Drugs Product
Table 94. Samsung Bioepis Recent Developments/Updates
Table 95. Biogen Company Information
Table 96. Biogen Description and Business Overview
Table 97. Biogen Intravitreal Injection of Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Biogen Intravitreal Injection of Anti-VEGF Drugs Product
Table 99. Biogen Recent Developments/Updates
Table 100. Outlook Therapeutics Company Information
Table 101. Outlook Therapeutics Description and Business Overview
Table 102. Outlook Therapeutics Intravitreal Injection of Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Outlook Therapeutics Intravitreal Injection of Anti-VEGF Drugs Product
Table 104. Outlook Therapeutics Recent Developments/Updates
Table 105. Kanghong Pharmaceutical Company Information
Table 106. Kanghong Pharmaceutical Description and Business Overview
Table 107. Kanghong Pharmaceutical Intravitreal Injection of Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Kanghong Pharmaceutical Intravitreal Injection of Anti-VEGF Drugs Product
Table 109. Kanghong Pharmaceutical Recent Developments/Updates
Table 110. Qilu Pharmaceutical Company Information
Table 111. Qilu Pharmaceutical Description and Business Overview
Table 112. Qilu Pharmaceutical Intravitreal Injection of Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Qilu Pharmaceutical Intravitreal Injection of Anti-VEGF Drugs Product
Table 114. Qilu Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Intravitreal Injection of Anti-VEGF Drugs Distributors List
Table 118. Intravitreal Injection of Anti-VEGF Drugs Customers List
Table 119. Intravitreal Injection of Anti-VEGF Drugs Market Trends
Table 120. Intravitreal Injection of Anti-VEGF Drugs Market Drivers
Table 121. Intravitreal Injection of Anti-VEGF Drugs Market Challenges
Table 122. Intravitreal Injection of Anti-VEGF Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Intravitreal Injection of Anti-VEGF Drugs
Figure 2. Global Intravitreal Injection of Anti-VEGF Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Intravitreal Injection of Anti-VEGF Drugs Market Share by Type: 2025 & 2032
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Fusion Proteins Product Picture
Figure 6. Global Intravitreal Injection of Anti-VEGF Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Intravitreal Injection of Anti-VEGF Drugs Market Share by Application: 2025 & 2032
Figure 8. Wet Age-Related Macular Degeneration
Figure 9. Diabetic Macular Edema
Figure 10. Macular Edema Secondary to Retinal Vein Occlusion
Figure 11. Others
Figure 12. Global Intravitreal Injection of Anti-VEGF Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Intravitreal Injection of Anti-VEGF Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global Intravitreal Injection of Anti-VEGF Drugs Sales (K Units), 2021–2032
Figure 15. Global Intravitreal Injection of Anti-VEGF Drugs Average Price (US$/Unit), 2021–2032
Figure 16. Intravitreal Injection of Anti-VEGF Drugs Report Years Considered
Figure 17. Intravitreal Injection of Anti-VEGF Drugs Sales Share by Manufacturers in 2025
Figure 18. Global Intravitreal Injection of Anti-VEGF Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Intravitreal Injection of Anti-VEGF Drugs Players: Market Share by Revenue in Intravitreal Injection of Anti-VEGF Drugs in 2025
Figure 20. Intravitreal Injection of Anti-VEGF Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Intravitreal Injection of Anti-VEGF Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Intravitreal Injection of Anti-VEGF Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Intravitreal Injection of Anti-VEGF Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Intravitreal Injection of Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Intravitreal Injection of Anti-VEGF Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Intravitreal Injection of Anti-VEGF Drugs by Type (2021–2032)
Figure 55. Global Intravitreal Injection of Anti-VEGF Drugs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Intravitreal Injection of Anti-VEGF Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Intravitreal Injection of Anti-VEGF Drugs by Application (2021–2032)
Figure 58. Global Intravitreal Injection of Anti-VEGF Drugs Price (US$/Unit) by Application (2021–2032)
Figure 59. Intravitreal Injection of Anti-VEGF Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
